Efficacy and Safety of Olodaterol Once Daily Delivered via Respimat® In Patients With GOLD 2–4 COPD: Results From Two Replicate 48-Week Studies
International Journal of COPD - New Zealand
doi 10.2147/copd.s61717
Full Text
Open PDFAbstract
Available in full text
Categories
Date
June 1, 2014
Authors
Publisher
Informa UK Limited